Dramatic response of pulmonary metastasis from prostatic cancer to LH-RH agonist treatment.
A case is presented of an elderly man with stage D2 cancer of the prostate who responded dramatically to hormonal manipulation utilizing LH-RH agonist. This case has three exceptional features: absence of bone metastasis; massive pulmonary metastasis; and rectal ulceration due to prostatic neoplasm. Although any type of hormonal manipulation could have achieved the same results, the use of LH-RH agonist has distinct advantages: minimal side effects and good patient tolerance.
Heyman
J
J
Leiter
E
E
D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D000368:Aged; D000369:Aged, 80 and over; D002064:Buserelin / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012002:Rectal Diseases / Q000209:etiology; D014456:Ulcer / Q000209:etiology
D007987:Gonadotropin-Releasing Hormone; D002064:Buserelin